Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Pediatric Infectious Disease Journal|September 18, 2014
First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsisSanet Torres-Torres, Angela L Myers, J Michael Klatte, et al.
Microbiology (Reading, England)|July 6, 2000
The newly characterized colicin Y provides evidence of positive selection in pore-former colicin diversificationM A Riley, Luis Cadavid, Marc S Collett, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2012
Characterization of poliovirus variants selected for resistance to the antiviral compound V-073Hong-Mei Liu, Jason A Roberts, Deborah Moore, et al.
The Pediatric Infectious Disease Journal|March 10, 2020
Clearance of Immunodeficiency-associated Vaccine-derived Poliovirus Infection With PocapavirJulie Copelyn, Jeffrey R Hincks, Jo M Wilmshurst, et al.
Virology|November 17, 2009
Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirusAlexander A Rumyantsev, Zhen-xi Zhang, Qing-sheng Gao, et al.
The Journal of Infectious Diseases|October 16, 2014
Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradicationMark A McKinlay, Marc S Collett, Jeffrey R Hincks, et al.
The Journal of Infectious Diseases|December 10, 2016
Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge ModelMarc S Collett, Jeffrey R Hincks, Kimberley Benschop, et al.
Journal of Medicinal Chemistry|March 6, 2007
N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of novel orthopoxvirus egress inhibitorsThomas R Bailey, Susan R Rippin, Elizabeth Opsitnick, et al.
BMJ Global Health|September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in SwedenElizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
Journal of Virology|September 29, 2005
An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus ChallengeGuang Yang, Daniel C Pevear, Marc H Davies, et al.
Pageof 2